{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:39:35Z","timestamp":1762324775181,"version":"3.37.3"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["N42\/DBS\/000104"],"award-info":[{"award-number":["N42\/DBS\/000104"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237196","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T17:54:54Z","timestamp":1596822894000},"page":"e0237196","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-5228","authenticated-orcid":true,"given":"Anna","family":"Partyka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2510-7237","authenticated-orcid":true,"given":"Agnieszka","family":"Zag\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-1192","authenticated-orcid":true,"given":"Magdalena","family":"Kota\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jastrz\u0119bska-Wi\u0119sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Knutelska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mordyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Janiszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Weso\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"pone.0237196.ref001","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"CD Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"pone.0237196.ref002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.bp.114.156786","article-title":"Antidepressant use in 27 European countries: Associations with sociodemographic, cultural and economic factors","volume":"207","author":"D Lewer","year":"2015","journal-title":"Br J Psychiatry"},{"key":"pone.0237196.ref003","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000447034","article-title":"The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature","volume":"85","author":"AF Carvalho","year":"2016","journal-title":"Psychother Psychosom"},{"key":"pone.0237196.ref004","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: A comprehensive review and meta-analysis","volume":"71","author":"A Serretti","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"pone.0237196.ref005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3949\/ccjm.73.4.351","article-title":"Side effects of antidepressants: An overview","volume":"73","author":"EA Khawam","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"pone.0237196.ref006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2017.07.004","article-title":"Effects of psychopharmacological treatment with antidepressants on the vascular system","volume":"96\u201398","author":"KG Kahl","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"pone.0237196.ref007","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0025-6196(12)61375-5","article-title":"Pharmacology of Antidepressants\u2014Characteristics of the Ideal Drug","volume":"69","author":"E. Richelson","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"pone.0237196.ref008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/14756366.2016.1198902","article-title":"Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents","volume":"31","author":"A Zag\u00f3rska","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"pone.0237196.ref009","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"RD Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn th\u00e9rapie"},{"key":"pone.0237196.ref010","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fitote.2012.05.010","article-title":"Antispasmodic effect of 4\u2032-methylepigallocatechin on guinea pig ileum","volume":"83","author":"MB Da Rocha","year":"2012","journal-title":"Fitoterapia"},{"key":"pone.0237196.ref011","article-title":"Idalopirdine\u2014a small molecule antagonist of 5-HT6 with therapeutic potential against obesity","author":"M Dudek","year":"2015","journal-title":"Metab Brain Dis"},{"key":"pone.0237196.ref012","doi-asserted-by":"crossref","first-page":"e0141327","DOI":"10.1371\/journal.pone.0141327","article-title":"A comparison of the anorectic effect and safety of the alpha2-adrenoceptor ligands guanfacine and yohimbine in rats with diet-induced obesity","volume":"10","author":"M Dudek","year":"2015","journal-title":"PLoS One"},{"key":"pone.0237196.ref013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2016.02.047","article-title":"Pyrrolidin-2-one derivatives may reduce body weight in rats with diet-induced obesity","volume":"776","author":"M Dudek","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"pone.0237196.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01146","article-title":"HBK-17, a 5-HT 1A receptor ligand with anxiolytic-like activity, preferentially activates \u00df-arrestin signaling","volume":"9","author":"K Pytka","year":"2018","journal-title":"Front Pharmacol"},{"key":"pone.0237196.ref015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/mol.111.072801","article-title":"Quantifying ligand bias at seven-transmembrane receptors","volume":"80","author":"S Rajagopal","year":"2011","journal-title":"Mol Pharmacol"},{"key":"pone.0237196.ref016","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1016\/j.bmc.2015.05.042","article-title":"Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of \u03b2-arrestin-2","volume":"23","author":"N Stroth","year":"2015","journal-title":"Bioorganic Med Chem"},{"key":"pone.0237196.ref017","first-page":"1","article-title":"The preclinical discovery and development of paliperidone for the treatment of schizophrenia","author":"A Weso\u0142owska","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"pone.0237196.ref018","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1021\/acs.jmedchem.7b01898","article-title":"Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update","volume":"61","author":"MN Modica","year":"2018","journal-title":"J Med Chem"},{"key":"pone.0237196.ref019","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bmc.2016.12.039","article-title":"New N\u2014and O -arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT 7 and 5-HT 1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies","volume":"25","author":"S Intagliata","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"pone.0237196.ref020","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bmcl.2015.02.042","article-title":"Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT1A and 5-HT7 receptor ligands","volume":"25","author":"MN Modica","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"pone.0237196.ref021","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.3390\/ijms160818474","article-title":"Functional selectivity and antidepressant activity of serotonin 1A receptor ligands","volume":"16","author":"Z Chilmonczyk","year":"2015","journal-title":"Int J Mol Sci"},{"key":"pone.0237196.ref022","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/mol.106.026716","article-title":"Distinct signaling profiles of \u03b21 and \u03b22 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy","volume":"70","author":"S Galandrin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"pone.0237196.ref023","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1073\/pnas.1932276100","article-title":"Protean agonism at histamine H3 receptors in vitro and in vivo","volume":"100","author":"F Gbahou","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0237196.ref024","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1074\/jbc.M411695200","article-title":"Internalization and Src activity regulate the time course of ERK activation, by delta opioid receptor ligands","volume":"280","author":"N Audet","year":"2005","journal-title":"J Biol Chem"},{"key":"pone.0237196.ref025","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1471-4159.2005.03161.x","article-title":"Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2","volume":"93","author":"TD Werry","year":"2005","journal-title":"J Neurochem"},{"key":"pone.0237196.ref026","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2174\/1568026619666190911122040","article-title":"From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery","volume":"19","author":"J Sniecikowska","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"pone.0237196.ref027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lfs.2018.08.050","article-title":"Serotonin receptors in depression and anxiety: Insights from animal studies","volume":"210","author":"E \u017bmudzka","year":"2018","journal-title":"Life Sci"},{"key":"pone.0237196.ref028","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/17460441.2016.1160051","article-title":"The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder","volume":"11","author":"ZT Sahli","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"pone.0237196.ref029","first-page":"36","article-title":"Vortioxetine (brintellix): A new serotonergic antidepressant","volume":"40","author":"A D\u2019Agostino","year":"2015","journal-title":"P T"},{"key":"pone.0237196.ref030","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication Augmentation after the Failure of SSRIs for Depression","volume":"354","author":"MH Trivedi","year":"2006","journal-title":"N Engl J Med"},{"key":"pone.0237196.ref031","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0269881108097714","article-title":"Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: A systematic review","volume":"24","author":"R Whale","year":"2010","journal-title":"J Psychopharmacol"},{"key":"pone.0237196.ref032","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: Rationale and current status of research","volume":"27","author":"P Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"pone.0237196.ref033","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568007043482633","article-title":"5-HT7 receptors","volume":"3","author":"DR Thomas","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"pone.0237196.ref034","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","article-title":"Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression","volume":"51","author":"A Weso\u0142owska","year":"2006","journal-title":"Neuropharmacology"},{"key":"pone.0237196.ref035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.112.193995","article-title":"Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder","volume":"342","author":"P Bonaventure","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0237196.ref036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","article-title":"Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo","volume":"205","author":"AI Abbas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"pone.0237196.ref037","first-page":"171","article-title":"Pharmacological Profile of Lurasidone, a Novel Antipsychotic Receptor Activity","volume":"334","author":"T Ishibashi","year":"2010"},{"key":"pone.0237196.ref038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852900020216","article-title":"Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants","volume":"14","author":"RM Berman","year":"2009","journal-title":"CNS Spectr"},{"key":"pone.0237196.ref039","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits","volume":"16","author":"R Levy","year":"2006","journal-title":"Cereb Cortex"},{"key":"pone.0237196.ref040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","article-title":"Animal models of major depression: drawbacks and challenges","volume":"126","author":"B Planchez","year":"2019","journal-title":"J Neural Transm"},{"key":"pone.0237196.ref041","first-page":"e3638","article-title":"The mouse forced swim test","author":"A Can","year":"2012","journal-title":"J Vis Exp"},{"key":"pone.0237196.ref042","first-page":"52587","article-title":"The forced swim test as a model of depressive-like behavior","author":"R Yankelevitch-Yahav","year":"2015","journal-title":"J Vis Exp"},{"key":"pone.0237196.ref043","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: A review of antidepressant activity","author":"B Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"pone.0237196.ref044","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2014.08.001","article-title":"Disrupted MEK\/ERK signaling in the medial orbital cortex and dorsal endopiriform nuclei of the prefrontal cortex in a chronic restraint stress mouse model of depression","volume":"580","author":"YH Leem","year":"2014","journal-title":"Neurosci Lett"},{"key":"pone.0237196.ref045","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1046\/j.1471-4159.2001.00300.x","article-title":"Reduced activation and expression of ERK1\/2 MAP kinase in the post-mortem brain of depressed suicide subjects","volume":"77","author":"Y Dwivedi","year":"2001","journal-title":"J Neurochem"},{"key":"pone.0237196.ref046","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1038\/sj.npp.1301372","article-title":"Aberrant Extracellular Signal-Regulated Kinase (ERK) 5 Signaling in Hippocampus of Suicide Subjects","volume":"32","author":"Y Dwivedi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"pone.0237196.ref047","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment","volume":"61","author":"CH Duman","year":"2007","journal-title":"Biol Psychiatry"},{"key":"pone.0237196.ref048","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"\u03b2-Arrestins and Cell Signaling","volume":"69","author":"SM DeWire","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"pone.0237196.ref049","doi-asserted-by":"crossref","first-page":"35518","DOI":"10.1074\/jbc.M405878200","article-title":"Differential Kinetic and Spatial Patterns of \u03b2-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor","volume":"279","author":"S Ahn","year":"2004","journal-title":"J Biol Chem"},{"key":"pone.0237196.ref050","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.2174\/0929867325666180309110629","article-title":"Phosphodiesterase 10 Inhibitors\u2014Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery","volume":"25","author":"A Zagorska","year":"2018","journal-title":"Curr Med Chem"},{"key":"pone.0237196.ref051","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0278-5846(88)90039-5","article-title":"Anticholinergic side effects of tricyclic antidepressants and their management","volume":"12","author":"RA Remick","year":"1988","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"pone.0237196.ref052","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tips.2006.03.008","article-title":"The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity","volume":"27","author":"T Masaki","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"pone.0237196.ref053","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2017.04.004","article-title":"The clinical pharmacology of non-sedating antihistamines","volume":"178","author":"K Yanai","year":"2017","journal-title":"Pharmacol Ther"},{"key":"pone.0237196.ref054","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2165\/00002018-199411010-00003","article-title":"Adverse Effects of \u03b11-Adrenergic Blocking Drugs","volume":"11","author":"SG Carruthers","year":"1994","journal-title":"Drug Saf"},{"key":"pone.0237196.ref055","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM198910053211407","article-title":"Orthostatic Hypotension in the Elderly","volume":"321","author":"JF Desforges","year":"1989","journal-title":"N Engl J Med"},{"key":"pone.0237196.ref056","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2015.01.010","article-title":"Involvement of \u03b11B-adrenoceptors in the anti-immobility effect of imipramine in the tail suspension test","volume":"750","author":"CAS Ribeiro","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"pone.0237196.ref057","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hup.561","article-title":"Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs","volume":"19","author":"M Bourin","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"pone.0237196.ref058","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4140\/TCP.n.2014.124","article-title":"Potential role of mirtazapine in underweight older adults","volume":"29","author":"O Hilas","year":"2014","journal-title":"Consult Pharm"},{"key":"pone.0237196.ref059","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","article-title":"Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants","volume":"15","author":"H Himmerich","year":"2015","journal-title":"Endocrine, Metab Immune Disord Targets"},{"key":"pone.0237196.ref060","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/CIRCULATIONAHA.105.571919","article-title":"Gamma-Glutamyltransferase, Atherosclerosis, and Cardiovascular Disease","volume":"112","author":"M Emdin","year":"2005","journal-title":"Circulation"},{"key":"pone.0237196.ref061","first-page":"60","article-title":"Gamma-glutamylotranspeptydaza\u2014potencjalny czynnik ryzyka chor\u00f3b sercowo-naczyniowych?","volume":"7","author":"M Mo\u015bci\u0144ski","year":"2012","journal-title":"Cardiol J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T17:55:38Z","timestamp":1596822938000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237196"}},"subtitle":[],"editor":[{"given":"Michel","family":"Baudry","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237196","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}